SCHEMBL25798262

SCHEMBL25798262

Cc1ccccc1-c1nnc(N[C@@H]2CCCN(C)C2)cc1C

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 13/20 0.70
▸ IL1B P01584 11/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26647736 0.90 IL1B (0.77) NLRP3IL1B
SCHEMBL25798269 0.90 NLRP3 (0.66) NLRP3IL1B
SCHEMBL26772247 0.89 NLRP3 (0.74) NLRP3IL1B
SCHEMBL25798654 0.87 NLRP3 (0.63) NLRP3IL1B
SCHEMBL25798265 0.87 NLRP3 (0.63) NLRP3IL1B
SCHEMBL25798059 0.87 NLRP3 (0.65) NLRP3IL1B
SCHEMBL24575305 0.86 NLRP3 (0.75) NLRP3IL1B
SCHEMBL29696876 0.86 NLRP3 (0.75) NLRP3IL1B
SCHEMBL26938723 0.86 NLRP3 (0.75) NLRP3IL1B
SCHEMBL25798436 0.85 IL1B (0.84) NLRP3IL1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023129987-A1 PYRIDAZINE DERIVATIVES AS MODULATORS OF NLRP3 INFLAMMASOME AND RELATED METHODS Neumora Therapeutics, Inc. (US) 2023-07-06 — — WO disclosed
Send feedback